drugset / Trial / NCT00387309

Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus

NCT00387309

Phase 3 Completed 495 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the investigational MOA-728 regimen than with a placebo regimen.

Timeline

Start
2006-12
Primary completion
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified 12 mg Intravenous
Subject Methylnaltrexone Other / unclassified 24 mg Intravenous